Abstract: Inflammasomes are intracellular multiprotein complexes that comprise part of the innate immune response.
INTRODUCTION
1. THE INFLAMMASOME Inflammasomes, first described in 2002, are intracellular multiprotein complexes consisting of three elements: a molecular pattern recognition receptor (PRR), an apoptosis-associated specklike protein containing a caspase-recruitment domain (ASC) adaptor protein, and a caspase-1 enzyme. 1, 2 Inflammasomes are constitutive of the innate immune system, and are responsible for regulating the immunological response to several stimuli, whether exogenous, such as bacterial agents, or endogenous, such as neoplasia, by means of cytokine production and secretion. Inflammasome assembly and activation are triggered by the recognition of stimuli by PPR receptors, which interact with the ASC adaptor molecule. ASC protein is then linked to the procaspase-1, which is then cleaved, activating caspase-1. Activation of caspase-1 culminates in the cleavage of pro-IL-1β and pro-IL18, resulting in their active forms IL-1β and IL18, respectively, which stimulate the inflammatory response. 2, 3, 4 The activation of capase-1 through the inflammasome pathway is also capable of inducing pyroptosis, a type of inflammatory cell death. 5, 6 Inflammasomes are named in accordance with their intracellular receptor's nomenclature. Two receptor classes have already been identified: NLR-Nod like receptors, and ALR-AIM2-like receptors. At least 6 types of inflammasomes have been described: NLRP1, NLRP3, NLRP6, NLRP12, NLRC4/IPAF, and AIM-2. The first five are NLR receptors, whereas AIM-2 is an ALR receptor. 4, 7 Normal inflammasome function, with IL18 and especially IL-1β, synthesis, is required for the innate immune system to act effectively against pathogens (virus, fungi, and bacteria) and against other diseases, including some types of cancer. When its activity becomes excessive, deleterious effects may occur in the organism.
Since their definition, inflammasome disorders have been implicated in several pathologies, becoming a possible target for therapeutic action. 8 Hereditary fever syndromes represented the group of diseases initially associated with inflammasomes. 9 In addition to these, other syndromes have recently had their physiopathogenesis associated with inflammasomes, such as: metabolic diseases (type 2 diabetes, obesity, arteriosclerosis),(Alzheimer's, multiple sclerosis), 11, 12 autoimmune diseases (vitiligo, rheumatoid arthritis, type 1 diabetes, Addison's disease, lupus erythematosus), 13, 14 infections (HIV, Francisella tularensis, Legionella pneumophila, Listeria monocytogenes, Mycobacterium tuberculosis, varicella zoster virus, S. pneumoniae), 15, 16, 17, 18, 19, 20 and neoplasia (gastric, hepatic, colorectal, breast, and melanoma). 21, 22 2. AUTOINFLAMMATION VS. AUTOIMMUNITY When we speak of autoimmune diseases, we refer to adaptive immune disorders, involving inflammatory diseases with aberrant responses to autoantigens, controlled by B cells and T cells, with the presence of autoantibodies. 23 The concept of autoinflammatory disease first appeared in 1999 and gained strength after the inflammasome was defined in
2002. Autoinflammatory diseases refer to disorders in which local factors lead to the activation of innate immune system cells, such as macrophages, neutrophils, mast cells and NK cells, resulting in tissue damage in the absence of autoantigens and autoantibodies.
Since then, several diseases, previously described as autoimmune,
or not fitting any classifications, have been classified as autoinflammatory, or, at least, as having an autoinflammatory component in their physiopathogenesis. Some pathologies share autoimmune and autoinflammatory characteristics. 23, 24, 25 We will provide here a literature review on skin diseases associated with inflammasomes.
MONOGENIC AUTOINFLAMMATORY DISEASES
Monogenic autoinflammatory diseases constitute a group of rare hereditary syndromes that lead to exacerbated responses by the innate immune system and present some common characteristics among them: recurrent signs of systemic inflammation, such as fevers, with early onset in childhood; heredity, in many cases;
and frequent skin manifestations. Among these diseases, inflammasomopathies represent the most important group, and will be described below.
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1-CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES (CAPS)
Cryopyrin-associated periodic syndromes (CAPS) include three rare entities that form a spectrum: familial cold autoinflammatory syndrome, Muckle-Wells syndrome, and neonatal onset multisystem inflammatory disease. These syndromes result from mutations in tbe NLRP3 gene and in the 1q44 chromosome, with dominant autosomal inheritance and variable penetrance, but with some new mutation cases, especially in the syndrome's more serious spectrum. 26, 28, 29, 30 Over 90 mutations have been reported. 31 This disease's physiopathology is characterized by excessive IL-1β production by macrophages, monocytes, and chondrocytes. 32 In an animal model, Nakamura and Kambe demonstrated that dermis mast cells produced histamine, as well as IL-1β, and are mainly responsible for the production of this cytokine. 33 Manifestations tend to accompany patients throughout their lives, and prognosis depends mainly on the development of secondary amyloidosis, which predominantly affects the kidneys. Acute or chronic renal failure, secondary to amyloidosis, may be a severe complication of the disease. 28, 29 Colchicine is the first line medication for treatment, leading to the reduction of inflammatory symptoms. Anakinra, thalidomide, and anti-TNF-α agents are therapeutic options.
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3-HYPER IGD SYNDROME (HIDS)
This syndrome is caused by autosomal recessive mutation in the MVK (mevalonate kinase) gene. Enzyme deficiency culminates in the increased caspase-1 activity and, consequently, in the synthesis of IL-1β. 41 Symptoms usually begin in the first year of life, with episodes that last from 3 to 7 days, and that appear every 1 or 2 months, but which tend to become less frequent during adulthood. 42 4-PAPA SYNDROME: PYOGENIC ARTHRITIS, PYODERMA
GANGRENOSUM, AND ACNE
Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA syndrome) is a rare autosomal dominant disease, with mutation of the PSTPIP1/CD2BP1 gene on chromosome 15q. A deficiency in the inhibition of caspase-1 activation leads to an excessive production of IL-1β. 29, 44 A sporadic PAPA syndrome case, without mutation in the PSTPIP1/CD2BP1 gene has been described in prior literature. 45 Clinically, these syndromes appear in recurrent sterile arthritis in early childhood, which may progress with deformities.
Pyoderma gangrenosum lesions occur mainly on the distal portion of one's limbs, but cases with multiple disseminate lesions have also been reported. Skin abscesses may also occur. Cystic acne and hidradenitis occur during adolescence. 29, 30 The therapeutic response has varied in previosly reported cases, with IL-1 inhibitors being more effective to combat articular symptoms, and anti-TNF being more effective for skin conditions. 
5-SCHNITZLER SYNDROME
Classification of this syndrome as an autoinflammatory disease is still controversial. Some cases have been associated with autosomal dominant mutations on the NLRP3 gene, which could place it within the CAPS group, whereas, in other patients, this mutation has not been found. In a case series of 22 patients with autoinflammatory diseases associated with the mutation of the NLRP3 inflammasome, one of these patients was diagnosed with associated Sweet's syndrome. 53 In two case reports of patients diagnosed with Sweet's syndrome, and who had been unaffected by various therapies, improvement was observed after treatment with Anakinra, an IL1RA, which is the medication of choice for CAPS and other autoinflammatory diseases. 54, 55 Mutations in the PSTPIP1 gene, the same associated with PAPA syndrome, were identified in patients with isolated pyoderma gangrenosum. 
PSORIASIS
The classification of psoriasis as an autoimmune disease itself presents limited evidence 57 and has been questioned due to the absence of specific antibodies and defined autoantigens, to the non-activiation of B cells, and to the absence of genetic risk factors that are common in other autoimmune conditions. The presence of neutrophils in lesions and the participation of the innate immune response are characteristics that are similar between psoriasis and the group of autoinflammatory diseases. for the AIM2-inflammasome, culminating in the synthesis of IL-1β. 63 The current understanding favors a view of psoriasis as a systemic inflammatory disease, with participation in the innate and adaptive immune response, sharing common characteristics with autoinflammatory diseases. 58 
BEHCET'S DISEASE
Behcet's disease (BD) (Figure 3 ) is a systemic inflammatory pathology of still undefined etiology. Components of the innate and adaptive immunity seem to be a part of its physiopathogenesis. Some studies have evaluated the relation between BD and inflammasones. In one study conducted with 371 patients with BD, an association was found between the disease and the IFI16 single nucleotide polymorphism, a mediator of the AIM2-inflammasome pathway. 64 Four mutations of the NLRP3/cryopyrin gene were identified in a study conducted with 50 cases of BD. 65 However, another study was unable to demonstrate a greater activation of caspase-1 through the inflammasome pathway in dendritic cells and neutrophils of sick patients, as compared to the controls. in an analogous mechanism, which occurred in autoinflammatory diseases stemming from the mutation of NLRP3 inflammasome.
These authors suggest that these haplotypes of NLRP1 would be insuficiente to unleash the disease, but they could act as adjuvants.
The increased production of IL-1β can contribute to the pathogenesis of autoimmunity to facilitate the presentation of autoantigens. 
LUPUS ERYTHEMATOSUS
The participation of the inflammasome on the physiopathogenesis of systemic lupus erythematosus (SLE) has been a target of
Sweet's syndrome
Behcet's disease study in recent years. Two NLRP1 single nucleotide polymorphisms were associated with SLE, mainly with the development of nephritis, cutaneous lesions, and arthritis. NLRP3, AIM2, NLRC4, and caspase-1 polymorphisms showed not direct correlation. 14 In another study, evaluating SLEs that begin in childhood and adolescence, a relationship was found with the IL-1β polymorphism but not with NLRP1. 72 The relationship between IL-1β polymorphisms and the development of SLE has produced conflicting results in the literature. 73 By contrast, IL-18 polymorphisms have proven to be associated with the risk of the development of the disease. 74 The most reliable piece of evidence of the relationship between SLE and inflammasomes was found in lupus nephritis. As regards skin involvement, it is known that IL-18 seems to play an important role, as it presents an increased expression in the keratinocytes of patients with cutaneous lupus. 75, 76 Whether or not inflammasomes exert some sort of influence upon SLE's photosensitivity, however, is still under investigation, given that UVB radiation is capable of stimulating the synthesis of IL-1β in keratinocytes by activating the inflammasome. A reduction in the expression of the ASC protein and of the IL-18 was observed, a finding that the authors suggest to be a possible explanation for the loss of microbial homeostasis. 85 The participation of inflammasomes was also suggested due to the synthesis of IL-1β
by the keratinocytes stimulated by UVB radiation.
HIDRADENITIS SUPPURATIVA
The participation of inflammasones in the physiopathology of hidradenitis suppurativa (HS) (Figure 4 ) has already been previously suggested due to the increase in IL-1β observed in the lesions. 87 Corroborating this hypothesis, one recent study, analyzing 34 skin samples from 22 patients with HS, found a greater expression of NLPR3 and caspase-1 on the sick skin, as compared to normal skin. A greater caspase-1 activity in the keratinocytes of the affected skin was also observed. 88 One therapy with colchicine, an effective medication in other diseases with inflammasomes, such as familial mediterranean fever and gout, was evaluated in eight patients with HS, but it proved not to be beneficial. by the pattern recognition receptor NLRP3 in the epidermis, activating the inflammasome pathway, thus culminating in the production of the pro-inflammatory IL-1β cytokine. 90 was controversial, as it was significant in the case-control study, but it did not exist in the familial base study, suggesting only a modest role for NLRP1, which might be one of many risk factors for the development of atopic dermatitis. 96 
SKIN CANCER
The association between an inflammatory response and cancer continues to be controversial, and studies have shown the role of the activation of inflammasomes in tumorigenesis, both as a protective factor as will as a stimulating factor,
SQUAMOUS CELL CARCINOMA (SCC)
Drexler et al., in a study with mice, showed that the ASC protein would have a pro-inflammatory role in the tumor inflammatory infiltrate cells, in turn favoring the development of SCC, but with a contrary effect on the keratinocytes, acting as a tumor suppressor.
In this same work, the loss of ASC expression in the SCC lesions in human tissues was observed. 97 In one study conducted with SCC induced in mice, Gasparoto et al. demonstrated that the presence of the ASC and caspase-1 proteins play the role of protectors against both tumorigenesis and SCC progression. 98 Opposing this supposed protective factor of the inflammasome, it is well-known that ultraviolet radiation, the main risk factor for the development of SCC, is a potent trigger for the release of IL-1β, through the activation of the inflammasomes within keratinocytes. Therefore, though they are not IL-1β producers, it is still under debate whether or not cell tumors in fact benefit from the cytokines produced by the macrophages. 
INFECTIONS
The immediate response of the body against pathogens is given by the innate imune system, with the activation of the innate response regulating the prompting of the adaptive immune reponse. The understanding of the host response against infection has changed in recent years due to studies evaluating the role of inflammasomes. 106 
FUNGI
The fungi of the Malassezia genus are skin commensals, but are also involved in some skin diseases. Kistowska et al. showed that different species of Malassezia present the potential to activate the NLRP3 inflammasome in antigen-presenting cells, leading to a high synthesis of IL-1β. 107 The NLRP3 and NLRC4 inflammasomes play key roles in the innate response against mucosal infections, as reported by Candida in two published studies. 108, 109 In addition, the activation of inflammasomes seems to depend on the transformation from a yeast form to a filamentous form. 110, 111 The relevant function of the
NLRP3 inflammasome in the defense against infection caused by
Microsporum canis and Trichophyton schoenleinii was also verified. 112, 113 In one recently published study conducted with mice, the par-ticipation of inflammasomes in the body's defense against sporotrichosis was postulated. The caspase-1 activity and the synthesis of IL-1β
and IL-18 diminished during the period of greatest fungal proliferation and transitory immunosuppression prompted by the fungus. Different from that observed with NLRP3 in the infected skin, no NLRP1 expression was observed. However, the study was unable to conclude if this activation is beneficial for the host or if the propagation of the virus is necessary. 115 The role of the inflammasome in the response to infection by HPV-16 in keratinocytes was investigated, demonstrating the prompting of the formation of the AIM2 inflammasome, with a consequent synthesis of IL-1β. A possible pathway is being discussed in an attempt to understand the reason why the HPV infection persists in some individuals. 116 Differently from the intracytoplasmatic receptors (NLRP1, NLRP3, NLRC4, and AIM2), the IFI16 is an intranuclear pattern recognition receptor that proved to be capable of recognizing the herpes virus associated with Kaposi's sarcoma (HVSK), leading to the activation of the IFI16 inflammasome, with the synthesis of IL-1β. 117 Johnson et al. demonstrated that the type 1 herpes virus (HSV-1) activates the NLRP3 and IFI16 inflammasomes during the intial stages of the infection and that there is no participation of the AIM2 inflammasome. However, with the progression of the infection, the HSV-1 develops mechanisms to suppress this inflammatory response. 118 
BACTERIA
The relationship between the inflammasome and infection caused by Staphylococcus aureus has been studied in the literature.
One mechanism to spark the neutrophilic response against cutaneous infection was proposed. In this model, in the epidermal infection (impetigo or seconday surface infection), the response would mainly be through the synthesis of IL-1α in keratinocytes. In dermal or subcutaneous infections (cellulitis, abcess), a synthesis of IL-1β would occur by means of the inflammasome pathway, both by resident cells and by recruited tissue cells. 119 In one study conducted with mice, it was found that the neutrophilic response, essential to the formation of abscesses and the improvement of the infection, is mediated by the IL-1β and that the neutrophils themselves are the main cells responsible for the synthesis of this interleukin, through some given pathways, especially those of the NLRP3 inflammasome. 120 Nonetheless, the response associated with the inflammasome did not prove to be beneficial. The α-hemolysin, known as a bacteria virulence fator, is capable of stimulating the NLRP3 inflammasome, causing cell death. This inflammatory response on the part of the host through tissue necrosis limits the capacity of infection control. The inflammasome appears to be a possible target for future therapies against severe infections caused by S. aureus.
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Haemophilus ducreyi is an etiological agente of a canker sore.
Although it is an agent that is predominantly extracellular, some of its components can be recognized by the inflammasome. The mRNA expression of genes associated with the inflammasomes was investigated in the infected skin, showing an increase in the NLRP3, NLRC4, AIM2, caspase-1, caspase-4, caspase-5, and IL-1β expressions, illustrating that the inflammasome can participate in the innate immune response toward this pathogen. The synthesis of IL-1β in vitro in macrophages derived from monocytes, through the NLRP3 inflammasome pathway, was also observed. 
PRESSURE ULCER
Using a biomechanical experimental model, in which young and elderly human skin were submitted to pressure and ischemia, Stojadinovic et al. observed that the elderly skin already presented a lesser expression of the components of the inflammasome and that the pressure did not result in any changes. The synthesis of IL-1β, which was already low in the elderly skin, did not change during the study. In the young skin, the expression of NLRP3 and caspase-1, but not of the ASC adaptor protein, increased significantly with pressure. By contrast, the synthesis of IL-1β diminished, suggesting that the pressure can undo the link between the components of the inflammasome, thus reducing the quantity of IL-1β produced, even with the increased presence of these components.
It is also being debated whether or not the reduction in the innate immune response with age can be involved in the greater risk for the development of pressure ulcers . 124 
WOUND HEALING
The function of the inflammasome in the skin healing process is not well-defined in the literature, but some studies have treated the subject. In one in vitro model conducted with material from mice, genetic variations of NLRP1 showed the capacity to interfere in the production of cytokines that might be involved in the healing process. 125 The NLRP3 inflammasome may well be involved in slow healing in diabetic patients, as seen in the findings from a work conducted with diabetic and obese mice in which the blocking of this inflammasome led to an improvement in the healing process. 126 In another study with material from both humans and mice, it was postulated that the NLRP3 inflammasome may be continually ac-tivated within the macrophages present in the wounds of diabetic patients, and that this contributes to the difficulty of wound healing. 127 By contrast, another study conducted with mice showed that the NLRP3 inflammasome would be important in the initial stage of the healing process. 128 
DRUG REACTIONS
Weston and Uetrecht debate the role of the inflammasome in the genesis of idiosyncratic medication reactions. The majority of these reactions occur due to medication that produces reactive metabolytes. Four medications were evaluated, two of which are associated with cutaneous reactions (teleprevir and dimethyl fumarate) and two that are not related to cutaneous lesions (boceprevir and ethacrynic acid). Only the former medications were able to activate the inflammasome in monocytes of human peripheral blood. The hypothesis raised is that the capacity of the reactive metabolyte to stimulate the inflammasome would be a determining factor in the potential of a given medication to cause idiosyncratic reactions. 129 Another study proposed that the activation of the inflammasome may well be a fundamental part for the cutaneous rash that is caused by nevirapine. 130 Further study is warranted to corroborate these hypotheses. 2-Regarding the concept of autoinflammatory disease, it is correct to state that: a) it is an old and obsolete concept, which included diseases currently better classified as autoimmune. b) the presence of autoantigens and autoantibodies are essential to classify a pathology as autoinflammatory. c) autoinflammation and autoimmunity may coexist in a single disease, as a result of innate and adaptive immune system disorders, respectively. d) the activation of B and T cells is essential for the physiopathology of autoinflammatory diseases.
3-About cryopyrin-associated periodic syndromes (CAPS),
it is incorrect to state that: a) include a spectrum that encompasses familial cold autoinflammatory syndrome, Muckle-Wells syndrome, and neonatal onset multisystem inflammatory disease. b) result from mutations in NLRP3 inflammasome, leading to the excessive IL-1β synthesis. c) in familial cold autoinflammatory syndrome, previously called familial cold urticaria, episodes may be triggered by exposure to low ambient temperatures. d) treatment with IL1 receptor antagonist (Anakinra) provides discouraging results, and does not interfere in the disease's natural history.
4-What is the wrong association between disease and its skin symptoms? a) PAPA syndrome: ulcers, cystic acne, and hidradenitis. b) familial Mediterranean fever: erysipeloid erythema, pruriginous, lesions, and palmoplantar erythema. c) Schnitzler syndrome: macules, papules, and urticarial plaques that appear after exposure to cold. d) Hyper IgD syndrome (HIDS): oral and genital aphthae, painful papules and macules, and panniculitis.
5-About pyoderma gangrenous and Sweet's syndrome, we may state that: a) the hypothesis of these being autoinflammatory diseases is rejected due to clinical and histological differences in relation to hereditary autoinflammatory diseases. b) the undefined pathogeny and the similarity to hereditary autoinflammatory diseases make way for the hypothesis that they are associated with inflammasome disorders. c) experts on the subject have declared that they are against the association between pyoderma gangrenoum and autoinflammation. d) they have definitely been associated with inflammasome gene mutations. 12-Regarding eczema and inflammasome, it is incorrect to state that a) nickel may induce sensitization by means of NLRP3 inflammasome complex activation. b) innate and adaptive immunity may be part of the contact dermatitis sensitization mechanism. c) a contact allergen may stimulate IL-1β synthesis through the inflammasome pathway. d) their relation to atopic dermatitis is well documented.
13-In the skin oncology field, inflammasomes:
a) may participate in tumor genesis by means of ultraviolet radiation stimulus, leading to IL-1β synthesis. b) play a well-defined role as protector in squamous cell carcinoma. c) inflammasome activation is associated with a better prognosis in melanoma. d) it has been defined that inflammation acts as a protective factor in oncogenesis.
14-About the Anakinra drug, it is correct to state that: a) it is an IL-1 receptor antagonist. b) it is contraindicated in inflammasomepathies such as CAPS. c) it acts by reducing IL-1 synthesis. d) it acts by increasing IL-1 effect.
15-Pyroptosis is:
a) the inflammasome intracellular receptor activation mechanism. b) apoptosis induced by inflammasome activation. 18-Inflammasome activation represents: a) a mechanism that may be essential in fighting infections; b) a pathological mechanism, inactive in healthy individuals. c) a defense mechanism, inactive in hereditary diseases, such as familial Mediterranean fever. d) a mechanism restricted to cutaneous-mucous diseases.
19-Which of the words below is not associated with autoinflammatory diseases:
a) autoantibodies b) innate immunity c) inflammasome d) neutrophils 20-About psoriasis, it is correct to state that: a) it is caused by NLRP3 gene mutation and is considered a monogenic inflammasomepathy. b) it may be classified as a systemic inflammatory disease, with the participation of innate and adaptive immune response, and shares characteristics common to autoinflammatory diseases. c) it is a classical autoimmune disease. d) neutrophilic inflammatory infiltrates and the participation of adaptive immunity are similar characteristics to those in autoinflammatory diseases. 
Answer key
